Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSPE.L Regulatory News (SPE)

  • There is currently no data for SPE

Interim Management Statement

3 May 2012 07:00

RNS Number : 6214C
Sopheon PLC
03 May 2012
 



Embargoed Release: 07:00hrs Thursday 3 May 2012

 

 

SOPHEON PLC

("Sopheon" or the "Company")

 

INTERIM MANAGEMENT STATEMENT

 

Sopheon plc, the international provider of software and services that improve the financial return from innovation and product development investments, announces its first interim management statement for the period from1 January 2012 to the date of this announcement, in line with the requirements of the EU Transparency Directive.

 

After the good start to the year which we highlighted in our 2011 results announcement, sales activities have continued to increase. Highlights for the year to date include:

 

14 new and extension license orders achieved, in addition to a number of substantial services engagements. Business from existing customers remains strong, and a number of new customers have also been won. Revenue visibility for the full year from contracted business and recurring revenue streams now stands above £6.5 million, compared to £6.1 million a year ago. We expect to close additional business in the second quarter from a mix of new and existing customers. Services business remains strong, already absorbing new hires made in the first quarter.

  

We advanced our market presence across Europe with the addition of two sales representatives, building on the recent appointment of Jim Conroy as our European commercial leader. These additional hires were made with due caution given that global markets have not yet regained their poise and accurate prediction of the timing and value of individual sales remains challenging.

 

A major product milestone was achieved with the release of Accolade 8.0, the latest version of our flagship software solution. This landmark release offers enhanced support for project portfolio management and collaboration, integration with Microsoft's SharePoint® technology and a mobile application designed for use with iPhone® and iPad®.devices. Other features deepen our software's ease-of-configuration and ease-of-use. Reflecting input from a number of high-profile customers, we believe Accolade 8.0 sets a new standard for agility in managing innovation.

 

On the corporate front, Sopheon is actively considering the transfer of its listing from the regulated market operated by NYSE Euronext in Amsterdam to its exchange-regulated market, NYSE Alternext in Amsterdam. This would enable the Company to benefit from certain tax exemptions which the Board believe will make it more attractive to specialist investment funds. It will also reduce the regulatory burden associated with a fully regulated market like NYSE Euronext which the Board and its advisers consider to be disproportionate to a company of Sopheon's size and resources. NYSE Alternext is a well-recognized market with over 180 companies listed, representing a combined market capitalization of €5.9 billion. Since NYSE Alternext uses the same trading platform as NYSE Euronext, no change is expected to the mechanisms by which shareholders can buy and sell Sopheon shares. A resolution will be put to shareholders in connection with this proposed transfer at the forthcoming Annual General Meeting of the company, to be held at the offices of Squire Sanders (UK) LLP, 7 Devonshire Square, London EC2M 4YH on 13 June 2012 at 11:00am.  

 

Accolade® is a registered trademark of Sopheon plc. SharePoint® is a registered trademark of Microsoft Corporation. iPhone® and iPad®

are registered trademarks of Apple®

For further information contact:

 

Barry Mence, Chairman

Sopheon plc

Tel : + 44 (0) 1483 685 735

Arif Karimjee, CFO

Sopheon plc

Tel : + 44 (0) 1483 685 735

Charlotte Stranner/ Henrik Persson/ Victoria Bates

finnCap

Tel: +44 (0) 20 7600 1658

Guy McDougall/Heather Armstrong

Newgate Threadneedle

Tel : + 44 (0) 20 7653 9850

Claire Verhagen

Citigate First Financial

Tel : + 31 (0) 205 754 010

 

About Sopheon

Sopheon (LSE: SPE) is an international provider of software and services. Sopheon's solutions structure, align and manage innovation processes to help organizations generate more revenues and profits from new products. Sopheon's solutions are used by industry leaders throughout the world, including BAE Systems, BASF, Corning, Electrolux, Honeywell, Novartis and SABMiller. Sopheon is listed on the AIM Market of the London Stock Exchange and on the Euronext in the Netherlands. For more information, please visit www.sopheon.com. 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
IMSEAKSAEDXAEFF
Date   Source Headline
11th Apr 20167:00 amRNSDirectors Options and Shareholding
21st Mar 20167:00 amRNSAmendment to Terms of Convertible Loan Stock
17th Mar 20167:00 amRNSFinal Results
21st Jan 20168:29 amRNSAccolade Release 10.2
8th Jan 20167:00 amRNSTrading Update and Board Change
20th Oct 20159:33 amRNSDirector Dealing
19th Oct 20157:00 amRNSDirector Dealing
9th Oct 20153:41 pmRNSDirector Dealing
9th Oct 20151:12 pmRNSDirector Dealing
2nd Oct 20153:39 pmRNSDirector Dealing
23rd Sep 20157:00 amRNSAccolade Release 10.1
27th Aug 20157:01 amRNSHalf Yearly Report
1st Jul 20157:00 amRNSDirector Shareholding
10th Jun 20151:44 pmRNSResult of AGM
10th Jun 20157:00 amRNSAGM Statement
2nd Jun 20157:00 amRNSAccolade 10.0 release
15th May 20153:10 pmRNSNotice of AGM
7th May 201511:40 amRNSDIRECTOR SHAREHOLDING
23rd Apr 201511:10 amRNSDirector Shareholding
20th Apr 201511:43 amRNSDirector Shareholding
13th Apr 20152:03 pmRNSHolding(s) in Company
10th Apr 201511:05 amRNSHolding(s) in Company
8th Apr 20157:00 amRNSDELISTING FROM ALTERNEXT AMSTERDAM
19th Mar 20157:00 amRNSFinal Results
20th Feb 20157:00 amRNSSopheon Releases Accolade® 9.3
5th Feb 20154:12 pmRNSChange of Registered Office
28th Jan 20157:00 amRNSTrading Update
19th Dec 201410:30 amRNSResult of General Meeting
12th Dec 20143:00 pmRNSTrading Update
2nd Dec 20144:00 pmRNSProposed Share Subdivision
2nd Dec 20147:00 amRNSDirector/PDMR Shareholding
27th Oct 20144:15 pmRNSDirector/PDMR Shareholding
22nd Oct 20143:45 pmRNSDirector/PDMR Shareholding
21st Oct 20147:00 amRNSDirector/PDMR Shareholding
17th Oct 20141:50 pmRNSDirector/PDMR Shareholding
10th Oct 201411:15 amRNSResult of GM and Further re Share Consolidation
24th Sep 20147:00 amRNSAccolade 9.2 Release
12th Sep 20147:00 amRNSShare Consolidation
28th Aug 20147:00 amRNSHalf Yearly Report
11th Jun 201412:20 pmRNSResult of AGM
11th Jun 20147:00 amRNSAGM Statement
2nd Jun 20147:00 amRNSAmendment To The Terms Of Convertible Loan Stock
22nd May 20147:00 amRNSAlternext Amsterdam
1st May 20147:00 amRNSInterim Management Statement
22nd Apr 20147:01 amRNSSopheon Delivers Accolade Release 9.1
11th Apr 20147:00 amRNSWind Down Of Alternext Amsterdam
20th Mar 20147:01 amRNSTotal Voting Rights
20th Mar 20147:00 amRNSPreliminary Results
6th Mar 20147:00 amRNSNew Debt Facility
29th Jan 20148:00 amRNSTrading Update

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.